CAPR:US
$10.21
3.236%

Capricor Therapeutics Inc.
News & Events

Last updated: Jun 2, 2025, 7:56 PM ET

  1. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

    GlobeNewswire JUN 2, 2025 1:55 PM EDT
    NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of in...
    READ ARTICLE
  2. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

    PR Newswire JUN 1, 2025 10:00 AM EDT
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therape...
    READ ARTICLE
  3. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

    GlobeNewswire MAY 28, 2025 9:00 AM EDT
    NEW YORK, May 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inv...
    READ ARTICLE
  4. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

    PR Newswire MAY 26, 2025 10:00 AM EDT
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therape...
    READ ARTICLE
  5. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

    GlobeNewswire MAY 22, 2025 9:00 AM EDT
    NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inv...
    READ ARTICLE
  6. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

    PR Newswire MAY 20, 2025 9:00 AM EDT
    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therape...
    READ ARTICLE
  7. CAPR Investors Have Opportunity to Join Capricor Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

    PR Newswire MAY 20, 2025 5:26 AM EDT
    CAPR Investors Have Opportunity to Join Capricor Therapeutics, Inc. Fraud Investigation with the ...
    READ ARTICLE
  8. INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Capricor Therapeutics, Inc. - CAPR

    GlobeNewswire MAY 18, 2025 10:00 AM EDT
    NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inv...
    READ ARTICLE
  9. CAPR Investors Have Opportunity to Join Capricor Therapeutics, Inc. Fraud Investigation with the Schall Law Firm

    Business Wire MAY 16, 2025 6:36 PM EDT
    The Schall Law Firm , a national shareholder rights litigation firm, announces that it is inves...
    READ ARTICLE
  10. Capricor Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

    GlobeNewswire MAY 13, 2025 4:05 PM EDT
    Biologics License Application (BLA) for deramiocel in the treatment of Duchenne muscular dystroph...
    READ ARTICLE

Upcoming Events

Get notified of Capricor Therapeutics Inc.’s latest announcements, news, and event dates.
  • Upcoming earnings announcement (Unconfirmed)

    Aug 7, 2025
  • Upcoming dividend payout

    Not Available
  • Upcoming stock splits

    Not Available